INTERNATIONAL SOCIETY FOR      DISEASES OF THE ESOPHAGUS

  • Home
  • News & Events
  • Abstracts Highlights
  • Recurrence Rates After Multi-Modality Endoscopic Eradication Therapy for Dysplastic Barrett's Esophagus (BE) and Early Esophageal Cancer: Results From an International, Multi-Center Consortium

Recurrence Rates After Multi-Modality Endoscopic Eradication Therapy for Dysplastic Barrett's Esophagus (BE) and Early Esophageal Cancer: Results From an International, Multi-Center Consortium

01 Jul 2016 3:35 AM | Anonymous

Irving Waxman6, Sreekar Vennelaganti1, Prashanth Vennalaganti1,2, Jesica Brown2, Stefan Seewald9, Alessandro Repici3, Kevin Kennedy1, Vani J. Konda6, Mojtaba S. Olyaee2, Neil Gupta4, Benjamin Alsop1,2, Andrew S. Ross5, Rehan Haidry7, Gary W. Falk8, Daniel Buckles2, Ajay Bansal1,2, Sharad Mathur1,2, Prateek Sharma1,2
1 Gastroenterology and Hepatology, Kansas city VA Medical Center, Kansas City, Missouri, United States; 2Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, United States; 3Gastroenterology, Instituto Clinico Humanitas, Milan, Italy; 4Gastroenterology and Hepatology, Loyola University, Maywood, Illinois, United States; 5 Gastroenterology, Virginia Mason Medical Center, Seattle, Washington, United States; 6Gastroenterology and Hepatology, University of Chicago Medical Center, Chicago, Illinois, United States; 7Gastroenterology, University college London Hospital, London, United Kingdom; 8 Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States;9 Gastroenterology and Hepatology, Hirslanden, Zurich, Switzerland

Volume 83, Issue 5, Supplement, AB1-AB694
2016 DDW ASGE Program and Abstracts
21 May 2016 - 24 May 2016



© International Society for Diseases of the Esophagus 2016

Powered by Wild Apricot Membership Software